Laura Kärtner is a clinical psychologist and researcher. She received her M.Sc. in Psychology with a specialization in Clinical Psychology from the Julius-Maximilians-University Würzburg in 2019. Her previous research activity as a Research Assistant at the Centre for Psychedelic Resarch, Imperial College London, involved the planning and organization of studies on psychedelic microdosing and ibogaine, as well as assisting as a psychologist in studies involving the administration of psilocybin in healthy volunteers (INSIGHT study). She has joined the Department of Molecular Neuroimaging at the Central Institute for Mental Health (CIMH) Mannheim to conduct her PhD and her training as clinical psychologist. Her main research interests lie in the therapeutic potential and psychobiological mechanisms of psychoactive substances and associated context effects. During her training, she will be working as a therapist and researcher in the german randomized controlled trial investigating the “Efficacy and Safety of Psilocybin in Treatment-Resistant Depression” (EPIsoDE).